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Abstract 
Review on t(9;15)(p13;q24) PAX5/GOLGA6A, 
with data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
B-cell acute lymphoblastic leukemia (B-ALL) 
Note 
Was not taken into account in this review a case of 
diffuse large B-cell lymphoma in a 51 year-old 
male patient (Morrison et al., 1994). 
Epidemiology 
One case to date, a 21-year-old male patient with a 





There were additional numerial anomalies (+5, 
+21). 








391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation. Entry 
of common lymphoid progenitors into the B cell 
lineage depends on E2A, EBF1, and PAX5; 
activates B-cell specific genes and repress genes 
involved in other lineage commitments.  
Activates the surface cell receptor CD19 and 
repress FLT3.  
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements.  
Genes repressed by PAX5 expression in early B 
cells are restored in their function in mature B cells 
and plasma cells, and PAX5 repressed (Fuxa et al., 
2004; Johnson et al., 2004; Zhang et al., 2006; 





693 amino acids (aa); contains a coiled coil domain 
(aa 14-611), with 11 leucine zipper motifs (aa 360-
430).  
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PAX5/GOLGA6A fusion protein. 
 
 
Member of the golgin family of proteins, localizes 
to the Golgi apparatus. Its function is poorly known 
(Gilles et al., 2000). 




Fusion of PAX5 exon 6 to GOLGA6A exon 3. 
Fusion protein 
Description 
887 amino acids. The predicted fusion protein 
contains the DNA binding paired domain, the 
octapeptide, and the homeodomain of PAX5 and 
part of the coiled coil domain of GOLGA6A. 
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